2019 International Achievement Award
The Society annually presents an award to an outstanding
individual in recognition of their contributions and achievements in the resolution of
public environmental concerns. There are no specific criteria, no age limitations,
however, international scientific developments in toxicology are of special interest.
THE INTERNATIONAL SOCIETY OF REGULATORY
TOXICOLOGY AND PHARMACOLOGY
THE 2019 INTERNATIONAL ACHIEVEMENT AWARD TO:
Dr. Peter Goering, Ph.D., DABT, ATS
Research Toxicologist and Deputy Director
Division of Biology, Chemistry and Materials Science in the
Office of Science and Engineering Laboratories at the
U.S. FDA's Center for Devices and Radiological Health
ISRTP President David Sarvadi's introduction of Dr. Peter Goering, Ph.D.
We are extremely pleased to announce this year's recipient
of the International Society of Regulatory Toxicology and
Pharmacology's 2019 International Achievement Award, Dr. Peter
Goering, PhD, DABT, ATS is the Research Toxicologist and
Deputy Director, Division of Biology, Chemistry, and Materials
Science in the Office of Science and Engineering Laboratories at
the U.S. FDA's Center for Devices and Radiological Health at the
US Food and Drug Administration, Silver Spring, Maryland.
Currently, his research interests include
nanotechnology/nanotoxicology, elucidating new biomarkers of
toxicity, and the toxicology of metals. His nanotechnology
research focuses on addressing key challenges associated with the
evaluation of nanomaterial characterization and toxicity for
improving regulatory decision making and prediction of health
risks. He currently serves as CDRH liaison to the American
Society for Testing and Materials (ASTM) E56 standards
committee on Nanotechnology: Physical, Chemical, and
Toxicological Properties. He received his PhD from the Kansas
University Medical School and was a postdoctoral fellow at the
National Institute of Environmental Health Sciences and joined the
FDA Center in 1986. In his more than 30 years of research, Dr.
Goering has co-authored over 100 peer-reviewed publications and
book chapters, including in the Journal RTP. He is a Diplomate of
the American Board of Toxicology (DABT), and a Fellow of
Academy of Toxicological Sciences (ATS). He served as President
of the Society of Toxicology in 2015-16.
Dr. Goering's international reputation as an expert is
considerable and his scientific accomplishments have had a far-reaching impact and cover a broad range in the areas related to the assessment of potential
adverse biological responses associated with medical devices, and development of more
efficient, predictive, and sensitive toxicology/biocompatibility test methods.
A prolific author, he has produced over 80 research articles in peer-reviewed journals,
including high impact journals such as Nature Biotechnology, ACS Nano, and Toxicological
Sciences, made over 120 research presentations at national/international scientific meetings, and
has been invited by eminent editors to write 22 book chapters. Under his direction as Lab
Leader, the CDRH Laboratory of Toxicology and Biocompatibility has evolved steadily into a
unique resource and interconnected program of research, risk assessment, and
standards/guidance document development. He organizes and leads a multi-disciplinary team
of toxicologists, cell biologists, biomedical engineers, and risk assessment experts, which
provides state-of-the-art expertise in toxicology, biocompatibility, and health risk assessment to
support the regulatory and public health mission of the FDA and CDRH. With his growing
reputation, he has skillfully leveraged resources by attracting experts from academia,
government agencies, and the private sector to increase the productivity and value of the
We are most pleased to recognize Dr. Goering for his contributions and achievements
promoting sound toxicologic and pharmacologic science as a basis for regulation affecting
human safety and health, and the environment.
INTERNATIONAL ACHIEVEMENT AWARD RECIPIENTS
(2018) John Bailey, Ph. D.
(2017) Ernest E. McConnell, DVM, MS (Path)
(2015) James S. Bus, Ph.D., DABT, Fellow ATS
(2014) Jay I. Goodman, Ph.D.
(2013) John Fawell, Ph.D.
(2012) Michael L. Gargas, Ph.D.
Michael G. Bird, Ph.D., FRSC
Gio Batta Gori, Ph.D.
(2009) Michael Dourson,
Ph.D., DABT, ATS
Mildred S. Christian, Ph.D., Fellow, ATS
Schwetz, D.V.M., Ph.D<>
(2006) Elizabeth I. Anderson,
Jerome H. Heckman, Esq.
(2004) Lester M. Crawford,
(2003) Curtis D. Klaassen,
(1999) Dr. Alan Rulis,
Director, Office of Premarket Approval (OPA)
(1998) Dr. Roger O. McClellan, President, CIIT, Research
Triangle Park, NC
(1997) Dr. Ian C. Munro, Principal, FRCPath
(1996) Dr. John Higginson, Retired Professor of Medicine,
(1995) Robert C. Barnard, Esq., Cleary, Gottlieb, Steen &
(1994) Dr. Philip Abelson, Science Magazine, Washington, DC
(1993) Dr. C. Jelleff Carr, Managing Editor of RTP, Columbia, MD
(1991) Dr. John P. Frawley, Health & Environment
International, Ltd., Wilmington, DE
(1990) Dr. John Doull, University of Kansas Medical Center, Kansas
(1989) Dr. Frederick Coulston, Coulston Foundation, Alamogordo, NM
(1988) Dr. Robert A. Neal, Retiring President of CIIT, Research
Triangle Park, NC
(1987) Dr. Gaston A. Vettorazzi, Geneva, Switzerland and Dr. Frank
C. Lu, Miami, FL, WHO
Copyright 2019 ISRTP